Lanean...
Targeting angiogenesis for radioimmunotherapy with a (177)Lu-labeled antibody
PURPOSE: Increased angiogenesis is a marker of aggressiveness in many cancers. Targeted radionuclide therapy of these cancers with angiogenesis-targeting agents may curtail this increased blood vessel formation and slow the growth of tumors, both primary and metastatic. CD105, or endoglin, has a pri...
Gorde:
| Argitaratua izan da: | Eur J Nucl Med Mol Imaging |
|---|---|
| Egile Nagusiak: | , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5700843/ https://ncbi.nlm.nih.gov/pubmed/28821931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-017-3793-2 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|